The Cost-Effectiveness of Oral Semaglutide Versus Empagliflozin in Type 2 Diabetes in Denmark
AuthID
P-00V-SBR
P-00V-SBR
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service